— Know what they know.
Not Investment Advice
Also trades as: VERT.V (TSXV) · $vol 0M

CVVRF OTC

Vertical Exploration Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -95.8% 1Y: -94.7% 3Y: -98.6% 5Y: -92.4%
$0.00
+0.00 (+0.00%)
 
OTC · Basic Materials · Industrial Materials · Tech Score Neutral · Power 45 · $244646 mcap · 140M float · 0.054% daily turnover · Short 90% of daily vol

Balance Sheet Trends

Total Assets
$6M -0.1% ▼
5Y CAGR: +22.0%
Total Liabilities
$924K -5.1% ▼
5Y CAGR: +22.5%
Shareholders Equity
$5M +0.9% ▲
5Y CAGR: +21.9%
Cash & Investments
$45K +86.2% ▲
5Y CAGR: -12.0%
Total Debt
$0 +0.0% ▲
Net Debt
-$45K -86.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$2M$6K$293K$24K$45K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2M$6K$293K$24K$45K
Net Receivables$0$0$0$12K$5K
Inventory$0$6K$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$2M$77K$326K$45K$53K
Property, Plant & Equip.$4M$6M$6M$6M$461K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$6M
Total Non-Current Assets$4M$6M$6M$6M$6M
Total Assets$6M$6M$6M$6M$6M
— Liabilities —
Accounts Payable$152K$404K$362K$666K$0
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$760K
Total Current Liabilities$188K$453K$507K$812K$760K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$157K$159K$161K$163K
Total Non-Current Liabilities$0$157K$159K$161K$163K
Total Liabilities$188K$611K$666K$973K$924K
— Equity —
Common Stock$12M$12M$14M$14M$14M
Retained Earnings-$9M-$10M-$11M-$11M-$11M
Accumulated OCI$2M$2K$0$0$3M
Total Stockholders Equity$5M$5M$5M$5M$5M
Total Liabilities & Equity$6M$6M$6M$6M$6M
— Key Metrics —
Total Debt$0$0$0$0$0
Net Debt-$2M-$6K-$293K-$24K-$45K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms